Booster

The calls and text messages are relentless. On the other end are doctors and scientists at the top levels of the NIH, FDA and CDC.

The effectiveness of COVID-19 vaccine booster doses dropped well under 50 percent after four months against subvariants of the virus that causes COVID-19, according to a new study from the U.S. Centers for Disease Control and Prevention (CDC).

The protection against severe illness from so-called natural immunity remains superior to that bestowed by COVID-19 vaccines, according to a new study.

New study from Italian researchers find that COVID booster vaccines are less than 20 percent effective in combating the virus

VAERS data released Friday by the Centers for Disease Control and Prevention show 1,329,135 reports of adverse events from all age groups following COVID-19 vaccines, including 29,273 deaths and 241,910 serious injuries between Dec. 14, 2020, and July 1, 2022.

Pfizer has already profited billions of dollars from the COVID-19 pandemic, and it plans to do so for years to come via annual vaccinations and sales of its antiviral pill Paxlovid.

The Biden administration on Wednesday announced a $3.2 billion deal to purchase 105 million doses of Pfizer’s COVID-19 vaccine for a fall vaccination campaign, with options to buy up to 300 million doses.

Acting on a proposal of the European Commission, the European Parliament, as expected, voted on June 23 to renew the EU Digital COVID Certificate...

As we’ve been seeing in elections over the last year, education issues have become hot-button concerns for parents.

Infection comes days after meeting with 79-year-old Biden.